Fresenius secures $2.4 billion loan for APP buy
German healthcare group Fresenius has secured a $2.4 billion credit facility to finance its $3.7 billion acquisition of U.S. company APP Pharmaceuticals , it said on Wednesday.
By Agencies |
FRANKFURT: German healthcare group Fresenius has secured a $2.4 billion credit facility to finance its $3.7 billion acquisition of U.S. company APP Pharmaceuticals , it said on Wednesday.
A company spokesman said the loan, managed by Deutsche Bank, Credit Suisse and JP Morgan, comprised of a $650 million revolving facility, a $900 million loan at 2.875 percent over Libor and a $850 million loan at 3.5 percent over Libor.
Fresenius has said it plans to finance the purchase with a mix of debt and equity aimed at minimising the impact on Fresenius's credit ratings, with the largest portion through debt.
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
